Duration of illness and duration of untreated illness in relation to drug response in psychiatric disorders

被引:29
作者
Altamura, Alfredo Carlo [1 ]
Buoli, Massimiliano [1 ]
Serati, Marta [1 ]
机构
[1] Univ Milan, Dept Psychiat, Fdn IRCCS CaGranda Osped Maggiore Policlin, I-20122 Milan, Italy
关键词
GRAY-MATTER VOLUME; EPIDEMIOLOGIC 1ST-EPISODE PSYCHOSIS; CLINICAL PREDICTORS; 1ST EPISODE; HIPPOCAMPAL VOLUME; GREY-MATTER; ANXIETY DISORDER; PANIC DISORDER; SCHIZOPHRENIA; DEPRESSION;
D O I
10.2217/NPY.10.2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent literature considers duration of illness (DI) and duration of untreated illness (DUI) as important factors influencing outcome in many psychiatric conditions. The aim of the present article is to analyze the relationship between DI and DUI, and pharmacological response in the different psychiatric disorders with particular emphasis on neurodegenerative aspects. An updated review of the current literature was conducted through PubMed in order to compare different studies focused on DI and DUI, and treatment response in major psychoses and in depressive/anxiety disorders. A significant body of evidence shows that a prolonged DI and DUI is associated with brain abnormalities and poor treatment response, particularly in schizophrenia. Nevertheless, an increasing number of studies point toward a similar conclusion in mood and anxiety disorders as well, even though fewer studies have been published in this field. Given the relationship between a longer DI and DUI, and poor treatment response not only in schizophrenia but also in mood and anxiety disorders - specific intervention programs aimed to reduce the latency to treatment are definitely envisaged.
引用
收藏
页码:81 / 90
页数:10
相关论文
共 86 条
[1]   Duration of untreated illness in major depressive disorder: a naturalistic study [J].
Altamura, A. C. ;
Dell'Osso, B. ;
Mundo, E. ;
Dell'Osso, L. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (10) :1697-1700
[2]   Duration of untreated illness as a predictor of treatment response and clinical course in generalized anxiety disorder [J].
Altamura, A. Carlo ;
Dell'Osso, Bernardo ;
D'Urso, Nazario ;
Russo, Michela ;
Fumagalli, Sara ;
Mundo, Emanuela .
CNS SPECTRUMS, 2008, 13 (05) :415-422
[3]  
Altamura AC, 2007, INT CLIN PSYCHOPHARM, V22, P249
[4]  
Altamura A Carlo, 2005, Neuropsychiatr Dis Treat, V1, P345
[5]   Duration of untreated illness and suicide in bipolar disorder: a naturalistic study [J].
Altamura, A. Carlo ;
Dell'Osso, Bernardo ;
Berlin, Heather A. ;
Buoli, Massimiliano ;
Bassetti, Roberta ;
Mundo, Emanuela .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2010, 260 (05) :385-391
[6]   Designing outcome studies to determine efficacy and safety of antipsychotics for 'real world' treatment of schizophrenia [J].
Altamura, A. Carlo ;
Glick, Ira D. .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (07) :971-973
[7]   Some biological correlates of drug resistance in schizophrenia: A multidimensional approach [J].
Altamura, AC ;
Bassetti, R ;
Cattaneo, E ;
Vismara, S .
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2005, 6 :23-30
[8]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[9]   The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes [J].
Arango, C ;
Breier, A ;
McMahon, R ;
Carpenter, WT ;
Buchanan, RW .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (08) :1421-1427
[10]   Hippocampus and amygdalar volumes in patients with refractory obsessive-compulsive disorder [J].
Atmaca, Murad ;
Yildirim, Hanefi ;
Ozdemir, Huseyin ;
Ozler, Sinan ;
Kara, Bilge ;
Ozler, Zuhal ;
Kanmaz, Ebru ;
Mermi, Osman ;
Tezcan, Ertan .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (05) :1283-1286